If you or a loved one were diagnosed with Non-Hodgkin Lymphoma after using, working with or being exposed to Roundup or Glyphosate, you may be entitled to recover compensation from a Roundup Non-Hodgkin Lymphoma lawsuit or settlement.
A team of injury attorneys and class action lawyers is investigating potential roundup lawsuit claims of individuals who, after being exposed to Roundup herbicide, were diagnosed with non-hodgkin’s lymphoma.
Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, non-hodgkins lymphoma or NHL) is a group of blood cancers, which develop from lymphocytes, a type of white blood cell that helps the body fight infections. Lymphoma is a malignancy of the lymphatic system (a network of knots of tissue or lymph nodes that filter and drain waste products and fluids from body) where the lymph-node cells or the lymphocytes multiply and produce cancerous cells.
It has been estimated that more 81,500 non-hodgkin lymphoma cases are diagnosed each year in the United States and that about 20,700 people in the U.S. will die from non-hodgkin lymphoma.
Roundup Non-Hodgkin Lymphoma Lawsuit Cases
Non-Hodgkin’s Lymphoma lawsuit claims potentially being investigated include claims of individuals who used Roundup weed killer or other glyphosate containing herbicides or pesticides and were subsequently diagnosed with Non-Hodgkin Lymphoma, including:
- B-cell non-hodgkin lymphoma
- T-cell non-hodgkin lymphoma
- Natural killer NK-cell non-hodgkin lymphoma
- Diffuse large B-cell lymphoma (DLBCL)
- Primary mediastinal (thymic) large B-cell lymphoma (PMBCL)
- Marginal zone B-cell lymphoma (MZL)
- Mantle cell lymphoma (MCL)
- Chronic lymphocytic leukemia (CLL)
- Small lymphocytic lymphoma (SLL)
- Lymphoplasmacytic lymphoma
- Waldenstrom macroglobulinemia
- Burkitt lymphoma
- B-lymphoblastic leukaemia/lymphoma
- Hairy Cell Leukemia
- Follicular lymphoma
- Primary CNS lymphoma
- Grey zone lymphoma (GZL)
- Cutaneous b-cell lymphoma
- Plasmablastic lymphoma
- Prolymphocytic leukemia
- T-cell lymphoma
- Peripheral T-cell lymphoma (PTCL)
- Mycosis Fungoides
- Sezary Disease
- Angioimmunoblastic t-cell lymphoma
- T-lymphoblastic lymphoma/leukemia
- Anaplastic large cell lymphoma (ALCL)
- Cutaneous t-cell lymphoma
- Adult t-cell leukemia/lymphoma
- Intestinal t-cell lymphoma
- Hepatosplenic T-cell lymphoma (HSTCL)
- Nasal NK T-cell lymphoma
- Intravascular lymphoma
- Large cell lymphoma
- Low-grade lymphoma
- High-grade lymphoma
- Other types of non-hodgkin’s lymphoma (NHL)
More than 60 subtypes of NHL have been idenitifed, based upon how or where the cells grow in the body, whether the disease is slow growing or fast growing, whether the cancer originates in T cells or B cells, what the cells look like under a microscrope and their genetic characteristics.
Non-Hodgkin’s Lymphoma & Roundup Chemicals
Although many risk factors can affect a person’s chance of getting Non-Hodgkin Lymphoma, one potential risk factor is exposure to certain chemicals. For example, Non-Hodgkin Lymphoma lawsuits have alleged that exposure to glyphosate, the chemical found in Roundup weed killer, can increase the risk of getting Non-Hodgkin Lymphoma.
Non-Hodgkin Lymphoma Signs & Symptoms
Signs and symptoms of non-Hodgkin’s lymphoma can include:
- enlarged or swollen lymph nodes
- lumps or bumps under the skin
- lumps or bumps on the side of neck, armpit or groin
- chills
- weight loss
- tiredness or fatigue
- bone pain
- chest pain
- itchiness
- shortness of breath or cough
- severe or frequent infections
- easy bruising or bleeding
- swollen abdomen (belly)
- B symptoms (fever, night sweats)
- bulky disease
- other non-Hodgkin lymphoma symptoms
Tests and procedures used to diagnose non-hodgkin lymphoma can include physical exam of the body (including lymph nodes, liver, and spleen) by a hematopathologist (a doctor specializing in diagnosing diseases of the blood and marrow), lymph node biopsy (usually of tissue from lymph nodes in the neck, under an arm, or in the groin), bone marrow aspiration and bone marrow biopsy, imaging tests (such as CAT scans, PET scans, MRI, etc.), and blood tests or lab tests (such as immunophenotyping, flow cytometry, cytogenetic analysis, gene expression profiling and microarray analysis).
Non-Hodgkin Lymphoma Cancer Treatement
Non-hodgkin lymphoma treatments, which can vary depending on the type and stage of NHL, how quickly the cancer is growing, the patient’s age, whether the patient has other health problems, side effects or symptoms and patient preferences, can include:
- Chemotherapy (e.g., R-CHOP regimen)
- Radiation therapy
- Maintenance cancer therapy
- Surgery (to remove organs and/or tumors)
- Autologous transplant
- Targeted therapy (e.g., monoclonal antibodies, kinase inhibitors, etc.)
- Immunotherapy (e.g., CAR T-cell therapy)
- Bone marrow transplant
- Other non-hodgkin lymphoma treatment
Non-Hodgkin Lymphoma Grades
Non-hodgkin lymphomas can be characterized as low-grade lymphoma (or indolent lymphoma) or high-grade lymphoma (or aggresive lymphoma). High-grade NHLs (such as diffuse large B-cell lymphomas) typically grow and spread quickly and are associated with severe symptoms. Low-grade NHLs (such as follicular lymphoma), typically grow slower and have fewer signs or symptoms when diagnosed.
Non-Hodgkin’s Lymphoma Stages
There are generally four stages of non-hodgkin lymphoma. In stage I non-hodgkin lymphoma, the lymphoma is in only one lymph node area or lymphoid organ or is in one area of one organ outside the lymph system. In stage II non-hodgkin lymphoma, lymphoma has spread to two or more lymph node areas on one side of the diaphragm or the lymphoma has spread into one organ and nearby lymph nodes. In stage III non-hodgkin lymphoma, the lymphoma is in lymph nodes on both sides of the diaphragm or above diaphragm and in the spleen. In stage IV non-hodgkin lymphoma, the cancer has metastasized widely into one or more organs outside the lymph systems, such as bones, liver or lung.
The 5-year relative survival rate for those diagnosed with non-hodgkin lymphoma is 73.8 percent, though the sooner it is identified the better: the 5 year survival rate for those with Stage I non-hodgkin lymphoma is 86.5 percent, for those with Stage II non-hodgkin lymphoma it is 78.1 percent, for those with Stage III non-hodgkin lymphoma it is 72.3 percent and for those with Stage IV non-hodgkin lymphoma it is 63.9 percent.
If you or someone you love were diagnosed with non-Hodgkin’s Lymphoma after using Roundup or glyphosate, you may be entitled to compensation from a Non-Hodgkin’s Lymphoma lawsuit or settlement. Contact an injury lawyer to request a free case review
Note: If you were diagnosed with non-Hodgkin’s lymphoma after using a recalled Philips CPAP breathing machine, you may also be entitled to compensation from a Philips CPAP lawsuit case or settlement claim.
Note: In addition, if you were diagnosed with non-Hodgkin lymphoma after being exposed to contaminated water at Marine base Camp Lejeune, you may also be able to recover compensation from a Camp Lejeune water contamination lawsuit.
*If you or a loved one are experiencing health issues, side effects or complications (i.e., non-Hodgkin’s Lymphoma symptoms) from a product, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company (i.e., Monstanto Company or Bayer) or product (i.e., Roundup) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form for a free attorney review.